New Perspectives in HCV Therapy: Entry Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|5|3|181-194

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.5, Iss.3, 2010-11, pp. : 181-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NS5A - From Obscurity to New Target for HCV Therapy

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 77-92

Bentham Science Publishers

Access to resources Recommend Favorite

New Perspectives of HIV/AIDS Therapy Study

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

Update on the development of HIV entry inhibitors

By Mastrolorenzo Antonio   Maresca Alfonso   Rusconi Stefano   Supuran Claudiu T  

Future HIV Therapy, Vol. 2, Iss. 5, 2008-09 ,pp. : 479-507

Future Medicine

Access to resources Recommend Favorite

Recent Patents on Nucleoside and Nucleotide Inhibitors for HCV

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 323-331

Bentham Science Publishers

Access to resources Recommend Favorite

Past, Present, and Future of Entry Inhibitors as HIV Microbicides

By  

Current HIV Research, Vol. 10, Iss. 1, 2012-01 ,pp. : 19-26

Bentham Science Publishers

Access to resources Recommend Favorite